%0 Journal Article
%T A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia
%A David Brown
%A Kristen Daniels
%A Michael Sand
%A Solen Pichereau
%J Archive of "Neurology and Therapy".
%D 2018
%R 10.1007/s40120-017-0085-5
%X Study desig
%K BI 409306
%K Cognitive outcome
%K Phosphodiesterase inhibitor
%K PDE9A
%K Pharmacokinetics
%K Phase I
%K Safety
%K Schizophrenia
%K Tolerability
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990500/